Publikasi

Novelty Nobility Expands AGC Biologics Deal to Take Pro...

The project leverages AGC Biologics’ global network, having completed cell line ...

‘Decision fatigue’ in hospitalists: What’s the biggest ...

High patient volume may be a bigger driver of “decision fatigue” in hospitalists...

Citius raises $36.5m for Lymphir commercialisation

The therapy is approved by the US Food and Drug Administration (FDA) for adult p...

MSD concludes Terns acquisition to expand CML pipeline

Following a successful tender offer and subsequent merger, the companies announc...

Gujarat’s bet on Jambusar 

Between the Gulf of Khambhat and the Narmada, India is staking 3,920 crores on ...

Haroli: Himachal’s next pharma play 

In Haroli, a quiet industrial location is being positioned at the centre of Ind...

India’s next pharma powerhouses

India’s pharma growth is increasingly being shaped not just by companies, but b...

The next wave 

India’s next pharma leap is being built from the ground up, through a new gener...

CURODONT REPAIR: redefining early-stage caries management

What happens when clinical experience meets emerging science? In a candid discus...

Colgate puts evidence into action at new event

Landing Forty Two in London provided a fitting backdrop for Colgate’s recent tho...

Bioengineered chewing gum could help fight head and nec...

The newly-developed chewing gum has been bioengineered to reduce levels of harmf...

Holista executes binding JV for collie collagen facility

Holista Colltech is pleased to announce that it has entered into a binding Join...

Genome Valley: Aligning with what comes next 

For years now, the Indian pharma industry has been talking about moving beyond ...

JNPC: Carrying forward a 20-year old legacy 

Billed as India’s first bulk drug, chemicals and allied manufacturing parks and...

Chromosome Engineering Reveals New Locus for Fusarium R...

A new Fusarium head blight resistance locus introgressed from Elymus repens has ...

UCB to Acquire Candid for up to $2.2B, Expanding Presen...

UCB said its planned acquisition of Candid plus an earlier licensing deal with A...